U-Blot® Research Grade PonsegromabCat. No. WA3376Request quote
Size: 50ug/100ug
Overview
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade PonsegromabCat. No. WA3376U-Blot® Research Grade PonezumabCat. No. WA3375Request quote
Size: 50ug/100ug
U-Blot® Research Grade PolzastobartCat. No. WA3374Request quote
Size: 50ug/100ug
U-Blot® Research Grade PolatuzumabCat. No. WA3373Request quote
Size: 50ug/100ug
U-Blot® Research Grade PogalizumabCat. No. WA3372Request quote
Size: 50ug/100ug
U-Blot® Research Grade PodentamigCat. No. WA3371Request quote
Size: 50ug/100ug
U-Blot® Research Grade PlutavimabCat. No. WA3370Request quote
Size: 50ug/100ug
U-Blot® Research Grade PlozalizumabCat. No. WA3369Request quote
Size: 50ug/100ug
U-Blot® Research Grade PlonmarlimabCat. No. WA3368Request quote
Size: 50ug/100ug
U-Blot® Research Grade PlamotamabCat. No. WA3367Request quote
Size: 50ug/100ug
U-Blot® Research Grade PlaculumabCat. No. WA3366Request quote
Size: 50ug/100ug
U-Blot® Research Grade PivekimabCat. No. WA3365Request quote
Size: 50ug/100ug
REQUEST A QUOTE
EMAILinfo@mail.ucallm.com
PHONE+(1)-866-986-9598
ONLINE FORMOnline Quote Submission
X+(1)-866-986-9598